Viridian Therapeutics
(NASDAQ:VRDN)
13.46
00
At close: May 23
13.46
00
PreMarket: 4:00PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low9.47 - 22
Open / Close- / -
Float / Outstanding26.4M / 27.9M
Vol / Avg.- / 181.9K
Mkt Cap375.9M
P/E-
50d Avg. Price16.21
Div / Yield-
Payout Ratio-
EPS-0.98
Total Float26.4M

Viridian Therapeutics (NASDAQ:VRDN), Quotes and News Summary

Viridian Therapeutics (NASDAQ: VRDN)

Day High/Low- - -
52 Week High/Low9.47 - 22
Open / Close- / -
Float / Outstanding26.4M / 27.9M
Vol / Avg.- / 181.9K
Mkt Cap375.9M
P/E-
50d Avg. Price16.21
Div / Yield-
Payout Ratio-
EPS-0.98
Total Float26.4M
Benzinga - May 16, 2022, 5:23AM
load more
Sector: Health Care.Industry: Biotechnology
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-1.080-0.980 0.1000
REV300.000K216.000K-84.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Viridian Therapeutics Questions & Answers

Q
How do I buy Viridian Therapeutics (VRDN) stock?
A

You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Viridian Therapeutics's (VRDN) competitors?
Q
What is the target price for Viridian Therapeutics (VRDN) stock?
A

The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by JMP Securities on Friday, March 11, 2022. The analyst firm set a price target for 31.00 expecting VRDN to rise to within 12 months (a possible 130.31% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Viridian Therapeutics (VRDN)?
A

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $13.46 last updated May 23, 2022, 8:00 PM UTC.

Q
Does Viridian Therapeutics (VRDN) pay a dividend?
A

There are no upcoming dividends for Viridian Therapeutics.

Q
When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?
A

Viridian Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Viridian Therapeutics (VRDN) going to split?
A

There is no upcoming split for Viridian Therapeutics.

Q
What sector and industry does Viridian Therapeutics (VRDN) operate in?
A

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.